Avelumab Program Rollover Study

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

205

Participants

Timeline

Start Date

March 22, 2019

Primary Completion Date

February 20, 2026

Study Completion Date

February 20, 2026

Conditions
Solid Tumors
Interventions
DRUG

Avelumab

Participants entering this roll over study will receive avelumab as a 1-hour intravenous (IV) infusion at 10 milligram per kilogram (mg/kg) once every 2 weeks until progressive disease, according to respective parent studies (EMR100070-001, EMR100070-002, EMR100070-004 and EMR100070-008).

Trial Locations (103)

20850

Maryland Oncology Hematology, P.A., Rockville

29425

Medical University of South Carolina (MUSC), Charleston

29605

Greenville Hospital System University Medical Center (ITOR) - Upstate Affiliate Organization, Greenville

30060

Northwest Georgia Oncology Centers, Marietta

34952

Hematology - Oncology Associates of the Treasure Coast - Hematology-Oncology Associates of Treasure Coast, Port Saint Lucie

37203

SCRI - Tennessee Oncology, Nashville

38138

The West Clinic, Germantown

45229

University of Cincinnati - PARENT, Cincinnati

45242

Oncology Hematology Care, Cincinnati

Oncology/Hematology Care Clinical Trials, LLC, Cincinnati

48910

Michigan State University, Lansing

55407

Virginia Piper Cancer Institute, Minneapolis

64131

Kansas City Research Institute, LLC - Phase I Unit, Kansas City

72703

Highlands Oncology Group, Fayetteville

77030

Oncology Consultants, P.A., Houston

78229

Henry Ford Hospital, San Antonio

85258

HonorHealth Research Institute, Scottsdale

95403

Providence Medical Foundation, Santa Rosa

St Joseph Heritage Healthcare, Santa Rosa

95817

University of California Davis Health System - Comprehensive Cancer Center, Sacramento

97201

Oregon Health & Science University, Portland

06850

Norwalk Hospital - The Whittingham Cancer Center, Norwalk

43210-1228

OSU - James Comprehensive Cancer Center, Columbus

02903

Rhode Island Hospital, Providence

75390-8857

University of Texas Southwestern Medical Center, Dallas

05401

University of Vermont Medical Center - Fletcher Allen Gastroenterology, Burlington

Unknown

Instituto Alexander Fleming, Ciudad Autonoma Buenos Aires

Clínica Universitaria Privada Reina Fabiola, Córdoba

Ballarat Health Services, Ballarat

Monash Medical Centre Clayton, Clayton

Centre Hospitalier de l'Ardenne - Pharmacie, Libramont

Clinique CHC MontLégia, Liège

Hospital de Câncer de Barretos - Fundação Pio XII, Barretos

MHAT for women's health - Nadezhda, OOD, Sofia

Nemocnice Rudolfa a Stefanie Benesov a.s. nemocnice Stredoceskeho kraje - parent, Benešov

Masarykuv onkologicky ustav - 300176866 Parent, Brno

CHU Besançon - Hôpital Jean Minjoz - Service d'oncologie Medicale, Besançon

Centre Oscar Lambret - Service d'Oncologie medicale, Lille

ICO - Site Paul Papin - service d'oncologie medicale, Nantes

ICO - Site René Gauducheau - Service d'Oncologie medicale, Nantes

Centre Antoine Lacassagne - Service d'Hématologie Oncologie, Nice

Institut Curie - site de Paris - Service d'Oncologie Médicale, Paris

CHU Bordeaux - Service d'Oncologie Médicale, Pessac

Groupe Hospitalier Sud - Hôpital Haut-Lévêque - Unité d'Explorations Fonctionnelles Respiratoires, Pessac

CHU Poitiers - Hôpital la Milétrie - service d'oncologie médicale, Poitiers

Centre Paul Strauss - Service de Médecine Oncologique, Strasbourg

Hopital Larrey - Service de Pneumologie et Oncologie Thoracique, Toulouse

Universitaetsklinikum Essen - Westdeutsches Tumorzentrum, Essen

Petz Aladar Egyetemi Oktato Korhaz - Pulmonologiai Osztaly, Győr

Zala Varmegyei Szent Rafael Korhaz - Pulmonologiai Osztaly, Zalaegerszeg

"Azienda Ospedaliera Universitaria- Università degli Studi della Campania Luigi Vanvitelli - Dipartimento Oncologia", Napoli

IOV - Istituto Oncologico Veneto IRCCS, Padua

Fondazione Policlinico Universitario Agostino Gemelli IRCCS - UOC Oncologia Medica, Roma

Istituto Nazionale Tumori Regina Elena IRCCS - UOC Oncologia Medica A, Roma

Istituto Clinico Humanitas - U.O. di Oncologia Medica ed Ematologia, Rozzano

National Cancer Center Hospital (NCCH), Chūōku

National Cancer Center Hospital - Dept of Gastrointestinal Oncology, Chūōku

Osaka Habikino Medical Center - Dept of Pulmonary Oncology, Habikino-shi

Cancer Institute Hospital of JFCR - Dept of Respiratory Medicine, Kōtoku

Kurume University Hospital - Dept of Lung Cancer Center, Kurume-shi

Osaka City General Hospital - Dept of Clinical Oncology, Osaka

Tohoku University Hospital, Sendai

Osaka University Hospital - Dept of Gastrointestinal Surgery, Suita-shi

Health Pharma Professional Research S.A. de C.V., México

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy - Dept of Lungs and Chest Oncology, Warsaw

"Institutul Oncologic Prof. Dr. Ion Chiricuta Cluj Napoca - Sectia Radioterapie III", Cluj-Napoca

S.C Radiotherapy Center Cluj S.R.L - Parent, Comuna Floresti

Institutul Regional de Oncologie Iasi - Sectia Oncologie Medicala, Iași

"Spitalul Clinic Municipal Dr. Gavril Curteanu Oradea - Centrul Oncologie Medicala", Oradea

S.C Oncomed S.R.L - Specialitatea Oncologie Medicala, Timișoara

"RBIH Kursk regional clinical oncology dispensary of Kursk Region Healthcare Committee", Kursk

"SBHI of Novosibirsk region Novosibirsk Regional Oncological Dispensary", Novosibirsk

"BHI of Omsk region Clinical Oncology Dispensary - Building #2", Omsk

"FSBI National Medical Research Center for Oncology n.a. N.N. Petrov of the MoH of the RF - Parent", Saint Petersburg

"LLC Medical Technologies - Parent", Saint Petersburg

Pavlov First Saint Petersburg State Medical University - PARENT, Saint Petersburg

Chungbuk National University Hospital, Cheongju-si

Chonnam National University Hwasun Hospital, Daejeon

National Cancer Center, Goyang

Gachon University Gil Medical Center, Incheon

Asan Medical Center, Seoul

Korea University Anam Hospital, Seoul

Samsung Medical Center, Seoul

Seoul National University Hospital, Seoul

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul

Hospital de la Santa Creu i Sant Pau - Dept of Oncology, Barcelona

Hospital Universitari Vall d'Hebron - Oncology Dept., Barcelona

Hospital General Universitario Gregorio Marañon - Servicio de Oncologia Medica, Madrid

Hospital de Mataro - Servicio de Oncologia Medica, Mataró

Songklanagarind Hospital - Department of Medicine, Songkhla

Adana City Hospital - Parent Account, Adana

Ankara University Medical Faculty - Medical Oncology, Ankara

Hacettepe University Medical Faculty - Oncology, Ankara

Goztepe Prof. Dr. Suleyman Yalcin City Hospital - Medical Oncology, Istanbul

Istanbul University Cerrahpasa - Cerrahpasa Medical Faculty - Medical Oncology, Istanbul

Medipol University Medical Faculty - Parent, Istanbul

Ege University Medical Faculty - PARENT, Izmir

Mersin University Medical Faculty - Medical Oncology, Mersin

CNE KHERSON REG ONCOLOGICAL DISPENSARY OF KHERSON RC - Day Hosp of Polycl with Outpatient Chemoth Room, Kherson

Podilskyi Regional Oncological Center - Dept of Chemotherapy, Vinnytsia

Sarah Cannon Research Institute UK, London

Mount Vernon Cancer Centre, Northwood

Derriford Hospital - Dept of Oncology Clinical Trials, Plymouth

All Listed Sponsors
collaborator

Merck KGaA, Darmstadt, Germany

INDUSTRY

lead

EMD Serono Research & Development Institute, Inc.

INDUSTRY